ARCHIVES

Two Phase II Studies of Ibrutinib Deliver High Response Rates

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Miami Core Grant Not Renewed, Status Threatened

September 21, 1990

No difference between digital or film mammograms, study finds.

September 23, 2005

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

May 9, 2003

ACS Approves New Workplaces Intervention Cancer Control Program

April 17, 1992

Vasopermeation Technology Awarded Patent For CA Firm.

September 28, 2001

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

May 21, 2004